Page last updated: 2024-09-03

l 158809 and l 158338

l 158809 has been researched along with l 158338 in 2 studies

Compound Research Comparison

Studies
(l 158809)
Trials
(l 158809)
Recent Studies (post-2010)
(l 158809)
Studies
(l 158338)
Trials
(l 158338)
Recent Studies (post-2010) (l 158338)
13707500

Protein Interaction Comparison

ProteinTaxonomyl 158809 (IC50)l 158338 (IC50)
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.001

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakravarty, PK; Chang, RS; Chen, TB; Faust, KA; Lotti, VJ; Mantlo, NB; Ondeyka, DL; Schorn, TW; Siegl, PK; Sweet, CS1
Anzini, M; Cappelli, A; De Benedetti, PG; Ferrari, F; Gallelli, A; Giorgi, G; Makovec, F; Mennuni, L; Menziani, MC; Pericot Mohr Gl, Gl; Rizzo, M; Vomero, S1

Other Studies

2 other study(ies) available for l 158809 and l 158338

ArticleYear
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:9

    Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Imidazoles; Purines; Rats; Tetrazoles

1991
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Journal of medicinal chemistry, 2004, May-06, Volume: 47, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Binding, Competitive; Computer Simulation; Crystallography, X-Ray; Drug Design; Imidazoles; In Vitro Techniques; Isometric Contraction; Ligands; Liver; Male; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Purines; Pyridines; Quinolines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrazoles

2004